Pendleton names former Nike veteran as new CEO
U.S. heritage brand Pendleton has announced the appointment of Jennifer Ingraffea to the role of chief executive officer, effective next month.
Helmed by the Bishop family for over one hundred years, Ingraffea replaces fifth generation family member John Bishop, the Portland, Oregon-based company's current CEO and president. She will be the third external CEO in the company's history, and the first-ever woman to serve in the role.
A sportswear veteran, Ingraffea joins the company from U.S. outerwear apparel brand, The North Face, where she served as chief product and merchandising officer.
Prior to the VF Corp.-owned brand, Ingraffea logged 19 years at sportswear giant Nike across various leadership roles, including her last role as global VP of kids footwear.
'We set a high bar for this search and are excited to have exceeded it,' said John Bishop. 'From our earliest conversations, it was clear Jenn's magnetic presence, her leadership style grounded in mentorship, and her ability to unite teams around a shared vision made her a natural fit for Pendleton. Jenn brings a decades-long career rooted in global product merchandising, and we look forward to her leading us in delivering compelling, market-relevant products to our customers.'
Founded in 1863, Pendleton has evolved from a textile manufacturer into an American icon known for its woolen blankets and throws, as well as knits and shirts.
'When I moved to the Pacific Northwest over two decades ago, Pendleton was one of the first brands that caught my attention. The history, legacy, and unparalleled craftsmanship drew me in immediately,' Ingraffea said. 'Now, I have the incredible opportunity to help shape its next chapter – to guide the brand toward the full promise of its potential.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
3 hours ago
- France 24
Putin T-shirts, robots and the Taliban -- but few Westerners at Russia's Davos
Once dubbed "Russia's Davos", the annual Saint Petersburg International Economic Forum (SPIEF) is designed to attract foreign investment and is the biggest showcase of Russian technology and business. Some 20,000 guests from 140 countries are set to take part in the forum over the next four days, both online and in person, according to the Kremlin. But for the fourth year running high-profile European and American representatives have been absent amid Moscow's offensive on Ukraine, a stark contrast to before the conflict, when some Western leaders would attend. Among the states sending high-level government figures this year are the likes of China, Vietnam, Iraq, Saudi Arabia, the Central African Republic and Burkina Faso. Taliban officials were also spotted at the expo, amid Russia's push to normalise ties with the militant Islamist group. Russian officials said some Western executives will attend. "American business representatives, but I can't say at what level," Kremlin aide Yuri Ushakov told reporters at a briefing Tuesday. According to the official programme, not a particularly high one. A panel on Thursday, titled simply "Russia-USA", will feature the head of the American Chamber of Commerce in Russia, some private investors, the founder of a microphone manufacturer and head of a crypto project. But in one high-profile win for Putin, Indonesian President Prabowo Subianto skipped an invitation to the G7 in Canada, choosing instead to meet Putin and attend SPIEF. Humanoid robot Among the events on the first day of the forum were panels focused on artificial intelligence and investment in the Global South. Russia has channelled its economic interests away from the West and towards emerging markets in Asia and Africa due to sanctions over the Ukraine conflict. One stand handed out T-shirts featuring quotes from Vladimir Putin and other government officials. One from Foreign Minister Sergei Lavrov read: "Why the hell did I come here?" Technology was also on display. A humanoid robot flaunting a Dior handbag was seen walking around the exhibits. The forum comes amid intense speculation in Russia about the prospect of sanctions relief and the return of Western firms that left the country after Moscow launched its offensive on Ukraine in February 2022. Hundreds of companies sold off, abandoned or gave away their Russian operations -- ranging from McDonald's and Nike to Ford and Goldman Sachs. Putin has at times blasted them for departing, warned they will not be allowed to return and said Russia is better off without them. He has also introduced punitive counter-sanctions, restricting the ability of firms from so-called "unfriendly" countries from accessing their profits and imposing huge exit fees and taxes on any wishing to leave. Trump's return to the White House and opening of diplomacy with Russia led to a frenzy of headlines in Russian media about whether he would ease US sanctions. Russia's top economic negotiator, Kirill Dmitriev, said Wednesday that the United States may "in the next couple of months" announce joint projects with Russia in the Arctic, without elaborating. "The very important process of improving relations between American society and American companies towards Russia is currently underway," he was quoted as saying by state media. Once a fixture of Europe's business calendar, SPIEF was where Western leaders, CEOs and major investors gathered to seal deals on entering and expanding their footprint in Russia. Then-German Chancellor Angela Merkel attended in 2013, as did Mark Rutte, the Netherlands' prime minister and now the Secretary General of NATO -- the man marshalling the military alliance's response to Putin's Ukraine offensive. Its prestige started to dip after 2014, when Russia annexed the Crimean peninsula from Ukraine and was hit with the first tranche of Western sanctions. But even as recently as 2018, French President Emmanuel Macron and Japan's then-Prime Minister Shinzo Abe sat on stage alongside Putin.
Euronews
4 hours ago
- Euronews
Could Europe bring in top research talent from the US?
US government spending on health research has reached a 10-year low, forcing universities to draw from their savings and hurting companies that sell lab supplies. Researchers who pursued global health, race, gender identity, climate change and topics related to diversity, equity and inclusion also saw their grants terminated. This has led to three-quarters of US-based respondents in a Nature poll considering leaving the country, creating an opportunity for the EU to attract researchers from the US. "We believe that diversity is an asset of humanity and the lifeblood of science. It is one of the most valuable global goods, and it must be protected," European Commission President Ursula von der Leyen said in May in a speech delivered at La Sorbonne University in Paris. In 2024, the US accounted for 36% of all highly cited researchers, compared to 21% in China and 19% in the EU (including Switzerland and Norway), according to a Bruegel analysis. While the EU retains a significant portion of its own talent, it also contributes substantially to the global pool of mobile top researchers, particularly to the US. Among US-based highly cited researchers at Harvard, Princeton, the University of Pennsylvania and Columbia, 7.7% earned their PhD in the EU. A large portion of the US-based top research workforce also has an international education, with 24% of US-based highly cited researchers being entirely educated abroad. Family ties, personal life plans and career prospects are among the factors that can persuade researchers to move countries. However, there is still a large salary gap between US and EU academics. A top researcher at the University of California can earn between $500,000 (€432,300) and over $1 million (€865,240) annually. In contrast, even the highest-paid professors at top European institutions such as Spain's Complutense University of Madrid typically earn no more than €77,122. Initiatives such as Choose Europe, which includes a €500 million package aimed at attracting researchers to Europe, alongside efforts to reduce barriers for international students and researchers, could lead to essential changes in the long run. For instance, Provence-Aix Marseille University reported being "inundated" with applications from US-based researchers after announcing the launch of the three-year Safe Place For Science program, where they expect to raise €15 million and host around 15 researchers. Yet, between 2022 and 2024, the most attractive destinations among US graduates who wanted to move abroad were the United Kingdom and Canada. "Life-changing plans take time, and it is too early to expect a massive outflow from the US," the Bruegel analysis stated. But 30 years of exposure to glyphosate has shattered his dreams and his existence. He was diagnosed five years ago with an intravascular B-cell lymphoma, a rare form of cancer. It has been recognised as an occupational disease. Glyphosate is the most widely used herbicide in the world and also the most controversial. It has been classified as 'probably carcinogenic' by the International Agency for Research on Cancer (IARC) since 2015. More recent studies from research institutes such as the French National Institute of Health and Medical Research (INSERM) have established a likely link between exposure to the chemical and certain forms of cancer. Yet, the European Union has extended its authorisation until 2033, relying on studies by EFSA and ECHA, the European authorities for food and chemical safety. Several environmental and consumer rights organisations challenged the decision before the European Court of Justice last April. The gap between assessments results from the methodologies used by research institutes and European regulatory agencies, according to Xavier Coumoul, a toxicologist and researcher at Inserm in France. 'When a pesticide manufacturer wants to market a product, the regulatory agencies require the manufacturer to conduct its own tests to prove the product is safe,' he explains. This process raises many questions surrounding the independence of these surveys. 'EFSA gives little consideration to epidemiological studies and relies considerably on what the industry provides, whereas Inserm or IARC rely much more on the academic literature and monitoring real-life product use.' Ludovic Maugé, whose life now hangs by a thread, is among those for whom the product's toxicity is undeniable. After undergoing more chemotherapy than is usually permitted, his last hope, he says, is a transplant using his own modified stem cells. It's a vanishingly small chance. 'As my oncologist told me, we can no longer speak of a cure,' he confides. Since his cancer was recognised as an occupational disease, Ludovic receives a modest social allowance, along with monthly compensation of 180 euros from Bayer-Monsanto — which manufactured the product that poisoned him. 'It's a pittance, but I don't care. What mattered most to me was to see my illness recognised as work-related.' Despite his daily ordeal, Ludovic, who can no longer work, wants to take his fight further. 'What I want is to spread the message to everyone. Glyphosate destroyed my life — it poisoned me. These products destroy people and destroy nature,' he insists. He is outraged by the EU's decision to renew glyphosate's authorisation. 'When I see politicians reauthorising these products, it makes me furious. It's the pesticide lobby. Unfortunately, we can't do anything against these politicians and Bayer-Monsanto. If I had one thing to say to the European Union, it's this: just ban these products. That's it.'
Euronews
5 hours ago
- Euronews
Rheinmetall partners with Anduril to build military drones for Europe
California-based Anduril Industries and Germany's largest arms manufacturer Rheinmetall announced on Wednesday that they would jointly develop drones and rocket motors under a new strategic partnership to serve European customers. The goal is to extend the available range of autonomous mission systems. Anduril's autonomous drones will be integrated into Rheinmetall's Battlesuite digital platform that links weapons systems As part of the collaboration, the two companies will come up with a European variant of Anduril's Barracuda, a low-cost, mass-producible drone, and Fury, a high-performance, multi-mission drone, both able to propel missiles. Rheinmetall and Anduril also confirmed they were working on rocket motors 'to help ensure European access to a reliable line of propulsion systems offering industrial redundancy and delivery at scale'. 'These systems will be jointly developed and produced by the two companies, incorporating sovereign suppliers and industrial partners throughout Europe,' said their statement. Rheinmetall's share price increased on Wednesday after the announcement, trading nearly 1% higher around midday in Europe. The defence giant has seen its share price nearly triple this year amid a boom in European military spending. Investor enthusiasm also earned the firm a place in the Euro Stoxx 50 benchmark index, in which it is going to start trading on 20 June, replacing Kering. Anduril has been on the lookout for partnerships as EU governments prepare to spend hundreds of billions of euros on defence in the next few years. In an attempt to reduce reliance on the US, the bloc is looking to favour homegrown players, prompting Anduril to emphasise Rheinmetall's active role in the partnership. Meanwhile, the US firm's British branch has recently cut a deal with the UK government to provide drones to Ukraine. In this episode of The Exchange, Laila Humairah explores the impact of Artificial Intelligence on industries worldwide. Laila Humairah speaks to Tanuja Randery, Managing Director at AWS about AI adoption in Europe, while Greg Fallon of explains generative AI solutions and highlights the importance of ethical considerations. Mohamed Elashi reports on Qatar's investments in AI. ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ ㅤㅤㅤ ㅤㅤㅤㅤ ㅤㅤㅤ ㅤㅤㅤ ㅤㅤㅤㅤㅤㅤㅤ ㅤㅤㅤㅤㅤㅤㅤㅤㅤ ㅤㅤㅤㅤㅤ ㅤㅤㅤㅤㅤㅤㅤㅤㅤ
